High T-cell response rate after COVID-19 vaccination in belimumab and rituximab recipients벨리무맙 및 리툭시맙 수혜자에서 COVID-19 백신 접종 후 높은 T 세포 반응률Article Published on 2022-05-012022-09-11 Journal: Journal of autoimmunity [Category] [DOI] 10.1016/j.jaut.2022.102827 PMC 바로가기 [Article Type] Article
COVID-19 severity and SARS-Cov-2 vaccine safety in pemphigus patients천포창 환자의 COVID-19 중증도 및 SARS-Cov-2 백신 안전성Multicenter Study Published on 2022-05-012022-09-12 Journal: Dermatologic therapy [Category] [DOI] 10.1111/dth.15417 PMC 바로가기 [Article Type] Multicenter Study
B Cell Characteristics at Baseline Predict Vaccination Response in RTX Treated Patients기준선에서의 B 세포 특성은 RTX 치료 환자의 예방 접종 반응을 예측합니다Article Published on 2022-04-192022-09-12 Journal: Frontiers in Immunology [Category] [DOI] 10.3389/fimmu.2022.822885 PMC 바로가기 [Article Type] Article
Case Report: Acquired Haemophilia A Following mRNA-1273 Booster Vaccination Against SARS-CoV-2 With Concurrent Diagnosis of Pleomorphic Dermal Sarcoma증례 보고서: 다형성 피부 육종의 동시 진단과 함께 SARS-CoV-2에 대한 mRNA-1273 추가 백신 접종 후 획득한 혈우병 ACase Reports Published on 2022-04-112022-09-11 Journal: Frontiers in Immunology [Category] [DOI] 10.3389/fimmu.2022.868133 PMC 바로가기 [Article Type] Case Reports
Immunogenicity of SARS-CoV-2 vaccination in rituximab-treated patients: Effect of timing and immunologic parameters리툭시맙 치료 환자에서 SARS-CoV-2 백신 접종의 면역원성: 시기 및 면역학적 매개변수의 영향Article Published on 2022-01-012022-09-12 Journal: Clinical immunology (Orlando, Fla.) [Category] [DOI] 10.1016/j.clim.2021.108897 PMC 바로가기 [Article Type] Article
COVID-19 outcomes in persons with multiple sclerosis treated with rituximab리툭시맙으로 치료받은 다발성 경화증 환자의 COVID-19 결과Article Published on 2022-01-012022-09-12 Journal: Multiple sclerosis and related disorders [Category] [DOI] 10.1016/j.msard.2021.103371 PMC 바로가기 [Article Type] Article
Embeddings from protein language models predict conservation and variant effectsArticle Published on 2021-12-302022-11-15 Journal: Human Genetics [Category] [DOI] 10.1007/s00439-021-02411-y PMC 바로가기
Incidence of COVID-19 in patients treated with infliximab compared with patients treated with rituximab리툭시맙으로 치료받은 환자와 비교하여 인플릭시맙으로 치료받은 환자에서 COVID-19 발생률Article Published on 2021-12-012022-09-12 Journal: RMD Open [Category] [DOI] 10.1136/rmdopen-2021-001711 PMC 바로가기 [Article Type] Article
[Are SARS-CoV-2 reactive T cells detectable and potentially protective in patients under anti-CD20 treatment with an impaired humoral response?][SARS-CoV-2 반응성 T 세포는 체액성 반응이 손상된 항-CD20 치료를 받는 환자에서 감지 가능하고 잠재적으로 보호 가능한가요?]Article Published on 2021-11-012022-09-11 Journal: Zeitschrift Fur Rheumatologie [Category] [DOI] 10.1007/s00393-021-01083-3 PMC 바로가기 [Article Type] Article
The Outcome of COVID-19 in Patients with a History of Taking Rituximab: A Narrative Review리툭시맙 복용 이력이 있는 환자의 COVID-19 결과: 내러티브 검토Review Published on 2021-11-012022-09-12 Journal: Iranian journal of medical sciences [Category] [DOI] 10.30476/IJMS.2021.88717.1946 PMC 바로가기 [Article Type] Review